Related Experiment Video
Updated: Dec 30, 2025

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Application of microphysiological systems in biopharmaceutical research and development
Norman C Peterson1, Prathap Kumar Mahalingaiah2, Aaron Fullerton3
1Clinical Pharmacology and Safety Sciences, AstraZeneca, One Medimmune Way, Gaithersburg, MD 20878, USA. ncpdvmphd@gmail.com.
Tissue microphysiological systems (MPS) mimic in vivo conditions for drug testing. This review highlights advances and challenges in applying MPS for biopharmaceutical preclinical research.
Area of Science:
- Biotechnology
- Pharmacology
- Toxicology
Background:
- Tissue microphysiological systems (MPS) have advanced significantly in the last decade.
- These systems retain in vivo morphologic and molecular characteristics.
- Their utility is validated by responses to small-molecule pharmaceuticals.
Purpose of the Study:
- To review advances in tissue-specific MPS.
- To outline advantages of MPS in biopharmaceutical research.
- To discuss challenges in applying MPS technology for large molecules.
Main Methods:
- Review of recent literature on tissue-specific MPS.
- Analysis of MPS applications in preclinical drug development.
- Evaluation of MPS for biopharmaceutical (large molecule) testing.
Main Results:
- MPS demonstrate retention of in vivo characteristics.
- MPS are increasingly recognized for biopharmaceutical development.
- Specific advantages and challenges for MPS application are identified.
Conclusions:
- MPS technology offers promising preclinical research applications.
- Further development is needed to optimize MPS for biopharmaceutical research.
- MPS can enhance toxicity testing strategies for new compounds.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Biopharmaceutics and Pharmacokinetics: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

